Skip to main content
SpringerLink
Log in

Über den Einfluß von Monoaminooxydase-Hemmern (MAOH) auf die Kreislaufwirksamkeit von oral eingenommenem m-Hydroxyphenyl(1)-aethanol(1)-amin (2)-hydrochlorid (Novadral)

  • Published:
Archiv für Kreislaufforschung Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Schrifttum

  1. Assali, N. undK. Dasgupta, J. Amer. Med. Ass.173, 1549 (1960).

    Google Scholar 

  2. Auerbach, H., Ärzt. Praxis9, Nr. 41 (1957).

  3. Axelrod, J. undR. Tomchick, J. Biol. Chem.233, 702 (1958).

    PubMed  Google Scholar 

  4. Axelrod, J., Parm. Rev.11 (1959).

  5. Axelrod, J., H. Weil-Malherbe undR. Tomchick, J. Pharm. Exp. Therap.127, 251 (1959).

    Google Scholar 

  6. Axelrod, J., Pharmacol.3, 48 (1961).

    Google Scholar 

  7. Axelrod, J., L. G. Whithby undG. Herlting, Science133, 383 (1961).

    PubMed  Google Scholar 

  8. Bächtold, H. P. undA. Pletscher, Abschwächung der Nor-Adrenalin-Wirkung auf die isolierte Aorta bei Hemmung der Monoaminooxydase Experientia15, 7, 265 (1959).

    PubMed  Google Scholar 

  9. Balzer, H. undP. Holtz, Arch. exper. Path. u. Pharm.227, 547 (1956).

    Google Scholar 

  10. Beer, D. T. undF. Schaffner, Fatal jaundise after administration of beta-phenylisopropylhydrazine; Referat in J. Amer. Med. Ass.171, 887 (1959).

    Google Scholar 

  11. Cesrman, T., Ann. N. Y. Acad. Sci.80, 988 (1959).

    PubMed  Google Scholar 

  12. Corne, S. J. undJ. D. P. Graham, J. Physiol.135, 339 (1957).

    PubMed  Google Scholar 

  13. Cossio, P., Ann. N. Y. Acad. Sci.80, 1009 (1959).

    PubMed  Google Scholar 

  14. Cossio, P., Amer. Heart J.56, 113 (1958).

    PubMed  Google Scholar 

  15. Credner, K. undK. Neugebauer, Arzneim.-Forschg.3, 462 (1953).

    Google Scholar 

  16. Credner, K., G. Renwanz undH. J. Hinze, Arch. exper. Pathol. u. Pharmakol.243, 85 (1962).

    Google Scholar 

  17. Davey, M. J., J. B. Farmer undH. Reinert, Hypotension and Monoaminooxidase Inhibitors. Int. Symp. MAOI, Lucerne (1961). Chemotherapia4, 314 (1962).

    PubMed  Google Scholar 

  18. Eakins, K. undM. F. Lockett, Brit. J. Pharmacol.16, 108 (1960).

    Google Scholar 

  19. Edelhoff, W., Med. Klin.49, 413 (1954).

    PubMed  Google Scholar 

  20. Engelhardt, A. undH. J. Schümann, Arzneim.-Forschg.3, 205 (1953).

    Google Scholar 

  21. v. Euler, N. S. undS. Hellner-Björkman, Acta physiol. Scand.33, Suppl.118, 21 (1955).

    PubMed  Google Scholar 

  22. v. Euler, N. S. undB. Zetterström, Acta physiol. Scand.33, Suppl.118, 26 (1955).

    PubMed  Google Scholar 

  23. Friedgood, C. E., Angiology11, 84 (1960).

    PubMed  Google Scholar 

  24. Funderburk, W. H., K. F. Finger, A. B. Drakontides undJ. A. Schneider, Ann. N. Y. Acad. Sci.96, 1, 289 (1962).

    PubMed  Google Scholar 

  25. Funderburk, W. H., K. F. Finger, A. B. Drakontides undJ. A. Schneider, Research2, 35 (1960).

    Google Scholar 

  26. Gaurot, P. O. et al., Experientia18, 260 (1962).

    PubMed  Google Scholar 

  27. Gertner, S. B., J. Pharmakol.131, 223 (1961).

    Google Scholar 

  28. Goldberg, L. I. undA. Sjoerdsma, J. Pharmacol. exper. Therap.127, 212 (1959).

    Google Scholar 

  29. Green, D. E. undD. Richter, Biochem. J.31, 596 (1937).

    Google Scholar 

  30. Griesemer, E. C., J. Barsky, C. A. Dragstedt, J. A. Wells undE. A. Zeller, Proc. Soc. Exper. Biol. Med.84, 699 (1953); Experientia11, 182 (1955).

    Google Scholar 

  31. Gross, H., Med. Welt11, 613 (1962).

    PubMed  Google Scholar 

  32. Guggenheim, M. undW. Löffler, Biochem.2, 72, 325 (1916).

    Google Scholar 

  33. Guggenheim, M., Die biogenen Amine (Basel-New York 1951).

  34. Heim, E., M. Konzelmann undH. Storck, Praxis1961, Nr. 41, 1067.

  35. Heinecker, R., K. E. Zipf undH. W. Lösch, Z. Kreislaufforschg.50, 1015 (1961).

    Google Scholar 

  36. Holtz, P., K. Credner undG. Kroneberg, Naunyn-Schmiedbergs Arch. exper. Path.-Pharmakol.204, 228 (1947).

    Google Scholar 

  37. Holtz, P., G. Kroneberg undH. J. Schümann, Naunyn-Schmiedbergs Arch. exper. Path.-Pharmakol.209, 364 (1950).

    Google Scholar 

  38. Holtz, P. undE. Westermann, Arch. exper. Path. Pharm.227, 538 (1956).

    Google Scholar 

  39. Holtz, P., K. Stock undE. Westermann, Naunyn-Schmiedebergs-Arch. exper. Path. Pharm.228, 322 (1956).

    Google Scholar 

  40. Holtz, P., Diskussionsbemerkung, S.73 und Considerations on the pharmacology of nialamide: inhibition of Monoamine oxidase and other mechanism, S. 520. Simposio International sobre Nialamida (Lissabon 1959).

  41. Holtz, P., W. Osswald undK. Stock, Arch. exper. Path.239, 239 (1960).

    Google Scholar 

  42. Horwitz, D., L. I. Goldberg undA. Sjoerdsma, J. Labor. Clin. Med.56, 747 (1960).

    Google Scholar 

  43. Jus, A., Clinical and laboratory investigation on the action of nialamide in certain mental disorders. Simposio Intern. sobre Nialamida 235 (1959).

  44. Kaczmarek, E. undH. Puppe, Arzneim.-Forschg.3, 208 (1953).

    Google Scholar 

  45. Kamijo, K., G. B. Koelle undH. H. Wagner, J. Pharmacol.117, 213 (1956).

    Google Scholar 

  46. Kirshner, N., C. McGoodall undL. Rosen, Proc. Soc. Exper. Biol. Med.98, 627 (1958); J. Pharmacol. Exper. Therap.127, 1 (1959).

    Google Scholar 

  47. Kline, N. S., H. P. Loomer undJ. C. Saunders, Amer. Psychiatr. Ass. Res.8, 129 (1957).

    Google Scholar 

  48. Knick, B., Arzneimitt.-Forschg.11, 843 (1961).

    Google Scholar 

  49. Kroneberg, G. undH. J. Schümann, Naunyn-Schmiedebergs Arch. exper. Path. Pharmakol.209, 350 (1959).

    Google Scholar 

  50. La Brosse, E. H., J. Axelrod undS. Kety, Science128, 593 (1958).

    PubMed  Google Scholar 

  51. Lundquist, G., Wien. med. Wschr.110, 721 (1960).

    PubMed  Google Scholar 

  52. Marguth, H. undH. Schaefer, Ber. ges. Physiol.139, 206 (1950).

    Google Scholar 

  53. Master, A. M., Amer. Heart J.56, 570 (1958).

    PubMed  Google Scholar 

  54. Minz, B. undE. Walaszek, Ann. N. Y. Acad. Sci.80, 617 (1959).

    PubMed  Google Scholar 

  55. Morador, J. L., La glucolisis and miocardio en las condicimos de isquemia; su relacion con sustancias inhibitoras de la MAO. Ann. Panamerican Symposium on Pharmacology and Therapeutics (Mexico 1961).

  56. Muscholl, E., The effect of Nialamide on the concentration of norepinephrine and adrenalin in the cardiac muscle and in the brain. Simposio Intern. s. Nialamida (1959).

  57. Neves, F. S. P., Nialamide in depressive syndromes. Simposio Intern. sobre Nialamida 204 (Lissabon 1959).

  58. Pisanty, J., A. Pineyro, R. Moreira undL. E. Todd, Further pharmacological studies on Nialamide: V. With respect to the chemical mediators of the automatic nervous system. Simposio Intern. sobre Nialamida 99 (Lissabon 1959).

  59. Pletscher, A., Dtsch. med. Wschr.86, I, 647 (1961).

    PubMed  Google Scholar 

  60. Pletscher, A. undB. Pellmont, J. Clin. Exper. Psychopathol.19, Suppl.1, 163 (1958).

    Google Scholar 

  61. Pletscher, A., K. F. Gey undP. Zeller, Arzneim.-Forschg.11, 417 (1960).

    Google Scholar 

  62. Popper, H., J. Amer. Med. Ass.168, 2235 (1958).

    Google Scholar 

  63. Richter, D., J. Physiol.98, 361 (1940).

    Google Scholar 

  64. Rivier, J. L., Experiences with Nialamide in the treatment of angina pectoris. Simposio Intern. sobre Nialamida 289, 512 (1950).

    Google Scholar 

  65. Robitzek, E. H., I. S. Selikoff undG. G. Ornstein, Anast. Bull. Sea View Hosp.13, 27 (1952).

    Google Scholar 

  66. Sarro, R., Wien. med. Wschr.110, 727 (1960).

    PubMed  Google Scholar 

  67. De Schaepdryver, A. F. undN. Kirshner, Science133, 586 (1961).

    PubMed  Google Scholar 

  68. Schayer, R. W., J. Biol. Chem.189, 301 (1951).

    PubMed  Google Scholar 

  69. Schlake, F., Münch. med. Wschr.1962, 555.

  70. Schneider, J. A., K. F. Finger undJ. Pereira, Chemotherapia4, 219 (1962).

    PubMed  Google Scholar 

  71. Schoner, W., Experimentelle Studien über die Beeinflussung der Wirkung sympathomimetischer Amine auf den Blutdruck nach Gaben des Monoamino-Oxydasehemmers Marsilid beim Menschen. Inaug. Dissert. (Mainz 1962).

  72. Schweizer, W., Ann. N. Y. Acad. Sci.80, 1016 (1960).

    Google Scholar 

  73. Shimamoto, T., H. Yamazaki, M. Inoung, T. Fujita, N. Sagawa, T. Sunaga undT. Ishioka, Proc. Japan Acad.36, 240 (1960).

    Google Scholar 

  74. Shimamoto, T. et al., Asian Med. J.4, Nr. 12, 5 (1961).

    Google Scholar 

  75. Sjoerdsma, A., L. Gillespie undS. Udenfriend, Ann. N. Y. Acad. Sci.80, 3; 969 (1959).

    PubMed  Google Scholar 

  76. Spector, S., D. Prokop, P. A. Shore undB. B. Brodie, J. Pharmacol. Exper. Ther.122, 71 (1958).

    Google Scholar 

  77. Spellberg, M. A. undJ. J. Frankel, Amer. J. Gastroenterol.1, 64 (1962).

    Google Scholar 

  78. Thaler, H., Wien. klin. Wschr.27, 477 (1959).

    Google Scholar 

  79. Voelkel, A., Psychiatr. Neurol., Basel140, 83 (1960); Ann. N. Y. Acad. Sci.80, 680 (1959); Wien. med. Wschr.110, 728 (1960).

    Google Scholar 

  80. Winson, T. undP. Zarco, Angiology11, 67 (1960).

    PubMed  Google Scholar 

  81. Zbinden, J. undS. Moeschlin, Cardiologia35, 62 (1959).

    PubMed  Google Scholar 

  82. Zeller, E. S., J. Barsky, J. R. Fonts undW. F. Kirchheimer, Experientia8, 349 (1952).

    Google Scholar 

  83. Zeller, E. A., J. Barsky undE. R. Berman, J. Biol. Chem.214, 267 (1955).

    PubMed  Google Scholar 

  84. Zimmermann, H. J., L. Rosenblum, R. J. Korn undP. E. Feldman, Ann. N. Y. Acad. Sci.80, 915 (1959).

    PubMed  Google Scholar 

  85. Heinecker, R., Arch. Kreislaufforschg.30, 1 (1959).

    Google Scholar 

Download references

Author information

Author notes

  1. R. Heinecker &  I. Nanay

    Present address: I. Med.-Univ.-Klinik, Süd 10, Ludwig-Rehn-Str. 14, 6000, Frankfurt am Main

Authors and Affiliations

    Authors
    1. R. Heinecker
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. I. Nanay
      View author publications

      You can also search for this author in PubMed Google Scholar

    Additional information

    Mit 7 Abbildungen und 4 Tabellen

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    Heinecker, R., Nanay, I. Über den Einfluß von Monoaminooxydase-Hemmern (MAOH) auf die Kreislaufwirksamkeit von oral eingenommenem m-Hydroxyphenyl(1)-aethanol(1)-amin (2)-hydrochlorid (Novadral). Archiv für Kreislaufforschung 42, 63–84 (1963). https://doi.org/10.1007/BF02119683

    Download citation

    • Received:

    • Issue Date:

    • DOI: https://doi.org/10.1007/BF02119683

    Search

    Navigation